123 related articles for article (PubMed ID: 9020296)
1. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
Lincoln S; Blessing JA; McGehee R; Lentz SS
Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.
Albain KS; Liu PY; Hantel A; Poplin EA; O'Toole RV; Wade JL; Maddox AM; Alberts DS
Gynecol Oncol; 1995 Jun; 57(3):407-11. PubMed ID: 7774846
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Feun LG; Blessing JA; Barrett RJ; Hanjani P
Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
[TBL] [Abstract][Full Text] [Related]
4. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.
Taylor SA; Benedetti J; Schuller D; Richman SP; Broun GO; Hantel A
Invest New Drugs; 1993; 11(2-3):227-9. PubMed ID: 8262737
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
8. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Malfetano J
Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
Plaxe SC; Blessing JA; Lucci JA; Hurteau JA
Invest New Drugs; 2001; 19(1):77-80. PubMed ID: 11291835
[TBL] [Abstract][Full Text] [Related]
11. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
Muss HB; Blessing JA; Eddy GL; McGehee R
Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.
Malviya VK; Liu PY; Goldberg DA; Hantel A; O'Toole RV; Roach RW; Conrad ME; Alberts DS
Anticancer Drugs; 1996 Jul; 7(5):527-30. PubMed ID: 8862719
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.
Hantel A; Tangen C; Gluck WL; Macdonald JS
Invest New Drugs; 1994; 12(2):159-61. PubMed ID: 7860236
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.
Ravdin PM; Green S; Doroshow JH; Martino S
Invest New Drugs; 1994; 12(4):333-6. PubMed ID: 7775136
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
Jacobs AJ; Blessing JA; Munoz A
Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
Muss HB; Sutton GP; Bundy B; Hatch KD
Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
Pazdur R; Bready B; Scalzo AJ; Brandof JE; Close DR; Kolbye S; Winn RJ
Invest New Drugs; 1994; 12(3):263-5. PubMed ID: 7896547
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Jenkins TR; Tangen C; Macdonald JS; Weiss G; Chapman R; Hantel A
Invest New Drugs; 1993 Nov; 11(4):329-31. PubMed ID: 8157474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
